Stockholders' Equity (Details Narrative) - USD ($)										3 Months Ended						9 Months Ended
	Sep. 23, 2020	Aug. 18, 2020	Jul. 28, 2020	Jul. 07, 2020	Jun. 04, 2020	May 15, 2020	Apr. 03, 2020	Feb. 20, 2020	Feb. 18, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Number of common stock shares issues
Common stock, par value										$ 0.02						$ 0.02		$ .02
Preferred stock shares desginated										200,000,000						200,000,000		200,000,000
Preferred stock liquidation per share										$ 1,000						$ 1,000		$ 1,000
Preferred stock liquidation value										$ 47,000,000						$ 47,000,000		$ 47,000,000
Stock compensation expense																$ 216,000	$ 203,000
Basic and diluted earnings per share																$ 0.08	$ 0.25
Number of common stock shares issues, value										$ 13,088,000	$ 6,185,000	$ 4,054,000	$ 162,000	$ 4,887,000	$ 638,000
Series A Convertible Preferred Stock [Member]
Preferred stock liquidation value		$ 1,000
Impact BioMedical, Inc. [Member]
Number of authorized shares of preferred stock		200,000,000
Preferred stock par value		$ 0.02
Impact BioMedical, Inc. [Member] | Series A Convertible Preferred Stock [Member]
Preferred stock shares desginated		46,868
Preferred stock liquidation per share		$ 1,000
Preferred stock liquidation value		$ 46,868,000
Beneficial ownership percentage		19.99%
Conversion price		$ 6.48
Conversion shares		154.32
Common Stock [Member]
Number of common stock shares issues										2,159,000	896,000	863,000	17,000	373,000	19,000
Conversion shares																7,233,000
Number of common stock shares issues, value										$ 43,000	$ 17,000	$ 18,000		$ 7,000
Common Stock [Member] | Impact BioMedical, Inc. [Member] | Series A Convertible Preferred Stock [Member]
Conversion shares		7,232,670
Mr. Heng Fai Ambrose Chan [Member]
Accrued salary																		$ 114,000
Board of Directors Member] | Common Stock [Member]
Shares vested							8,900
Share price							$ 0.66
Shares restricted stock issued							5,800
Investor [Member]
Number of common stock shares issues					21,000
Number of common stock shares issues, value					$ 210,000
Chief Executive Officer and the Chairman of the Board [Member] | Common Stock [Member]
Shares vested	20,000
Share price	$ 4.48
Underwriting Agreement [Member] | Mr. Heng Fai Ambrose Chan [Member]
Common stock were remitted in lieu of cash									11,664
Proceeds from net offering								$ 2,000,000
Underwriting Agreement [Member] | Underwriter Member]
Proceeds from net offering			$ 3,300,000	$ 6,700,000		$ 6,200,000		$ 4,000,000
Underwriting Agreement [Member] | Underwriter Member] | Common Stock [Member]
Number of common stock shares issues			453,333	1,028,800		769,230		740,741
Common stock, par value			$ 0.02	$ 0.02		$ 0.02		$ 0.02
Share issued price per shares			$ 7.50	$ 6.25		$ 7.80		5.40
Pre-reverse stock split per share								$ 0.18
Underwriting Agreement [Member] | Underwriter Member] | Additional Shares [Member]
Number of common stock shares issues			38,533	154,320		115,384		111,111